Imatinib Drugs Market Size, Share 2022

TABLE OF CONTENTS

1 Study Coverage
1.1 Imatinib Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Imatinib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsules
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Imatinib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Imatinib Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Imatinib Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Imatinib Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Imatinib Drugs Sales by Region
2.4.1 Global Imatinib Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Imatinib Drugs by Region (2023-2028)
2.5 Global Imatinib Drugs Revenue by Region
2.5.1 Global Imatinib Drugs Revenue by Region (2017-2022)
2.5.2 Global Imatinib Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Imatinib Drugs Sales by Manufacturers
3.1.1 Global Top Imatinib Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Imatinib Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Imatinib Drugs in 2021
3.2 Global Imatinib Drugs Revenue by Manufacturers
3.2.1 Global Imatinib Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Imatinib Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2021
3.3 Global Imatinib Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Imatinib Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Imatinib Drugs Sales by Type
4.1.1 Global Imatinib Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Imatinib Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Imatinib Drugs Sales Market Share by Type (2017-2028)
4.2 Global Imatinib Drugs Revenue by Type
4.2.1 Global Imatinib Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Imatinib Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Imatinib Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Imatinib Drugs Price by Type
4.3.1 Global Imatinib Drugs Price by Type (2017-2022)
4.3.2 Global Imatinib Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Imatinib Drugs Sales by Application
5.1.1 Global Imatinib Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Imatinib Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Imatinib Drugs Sales Market Share by Application (2017-2028)
5.2 Global Imatinib Drugs Revenue by Application
5.2.1 Global Imatinib Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Imatinib Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Imatinib Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Imatinib Drugs Price by Application
5.3.1 Global Imatinib Drugs Price by Application (2017-2022)
5.3.2 Global Imatinib Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Imatinib Drugs Market Size by Type
6.1.1 North America Imatinib Drugs Sales by Type (2017-2028)
6.1.2 North America Imatinib Drugs Revenue by Type (2017-2028)
6.2 North America Imatinib Drugs Market Size by Application
6.2.1 North America Imatinib Drugs Sales by Application (2017-2028)
6.2.2 North America Imatinib Drugs Revenue by Application (2017-2028)
6.3 North America Imatinib Drugs Market Size by Country
6.3.1 North America Imatinib Drugs Sales by Country (2017-2028)
6.3.2 North America Imatinib Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Imatinib Drugs Market Size by Type
7.1.1 Europe Imatinib Drugs Sales by Type (2017-2028)
7.1.2 Europe Imatinib Drugs Revenue by Type (2017-2028)
7.2 Europe Imatinib Drugs Market Size by Application
7.2.1 Europe Imatinib Drugs Sales by Application (2017-2028)
7.2.2 Europe Imatinib Drugs Revenue by Application (2017-2028)
7.3 Europe Imatinib Drugs Market Size by Country
7.3.1 Europe Imatinib Drugs Sales by Country (2017-2028)
7.3.2 Europe Imatinib Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Imatinib Drugs Market Size by Type
8.1.1 Asia Pacific Imatinib Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Imatinib Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Imatinib Drugs Market Size by Application
8.2.1 Asia Pacific Imatinib Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Imatinib Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Imatinib Drugs Market Size by Region
8.3.1 Asia Pacific Imatinib Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Imatinib Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Imatinib Drugs Market Size by Type
9.1.1 Latin America Imatinib Drugs Sales by Type (2017-2028)
9.1.2 Latin America Imatinib Drugs Revenue by Type (2017-2028)
9.2 Latin America Imatinib Drugs Market Size by Application
9.2.1 Latin America Imatinib Drugs Sales by Application (2017-2028)
9.2.2 Latin America Imatinib Drugs Revenue by Application (2017-2028)
9.3 Latin America Imatinib Drugs Market Size by Country
9.3.1 Latin America Imatinib Drugs Sales by Country (2017-2028)
9.3.2 Latin America Imatinib Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Imatinib Drugs Market Size by Type
10.1.1 Middle East and Africa Imatinib Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Imatinib Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Imatinib Drugs Market Size by Application
10.2.1 Middle East and Africa Imatinib Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Imatinib Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Imatinib Drugs Market Size by Country
10.3.1 Middle East and Africa Imatinib Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Imatinib Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Overview
11.1.3 Apotex Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Apotex Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Apotex Inc. Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Corporation Information
11.3.2 Sanofi S.A. Overview
11.3.3 Sanofi S.A. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi S.A. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi S.A. Recent Developments
11.4 Cipla Inc.
11.4.1 Cipla Inc. Corporation Information
11.4.2 Cipla Inc. Overview
11.4.3 Cipla Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cipla Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Inc. Recent Developments
11.5 Mylan Pharms Inc.
11.5.1 Mylan Pharms Inc. Corporation Information
11.5.2 Mylan Pharms Inc. Overview
11.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Pharms Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Pharms Inc. Recent Developments
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
11.6.2 Glenmark Pharmaceuticals Ltd. Overview
11.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Corporation Information
11.7.2 Sun Pharmaceuticals Overview
11.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharmaceuticals Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharmaceuticals Recent Developments
11.8 Actavis Generics
11.8.1 Actavis Generics Corporation Information
11.8.2 Actavis Generics Overview
11.8.3 Actavis Generics Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Actavis Generics Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Actavis Generics Recent Developments
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Corporation Information
11.9.2 Dr. Reddy's Laboratories Overview
11.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dr. Reddy's Laboratories Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr. Reddy's Laboratories Recent Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.10.2 Teva Pharmaceutical Industries Ltd. Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Imatinib Drugs Industry Chain Analysis
12.2 Imatinib Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Imatinib Drugs Production Mode & Process
12.4 Imatinib Drugs Sales and Marketing
12.4.1 Imatinib Drugs Sales Channels
12.4.2 Imatinib Drugs Distributors
12.5 Imatinib Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Imatinib Drugs Industry Trends
13.2 Imatinib Drugs Market Drivers
13.3 Imatinib Drugs Market Challenges
13.4 Imatinib Drugs Market Restraints
14 Key Findings in The Global Imatinib Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Imatinib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Capsules
Table 3. Major Manufacturers of Tablets
Table 4. Global Imatinib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Imatinib Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Imatinib Drugs Sales by Region (2017-2022) & (K MT)
Table 7. Global Imatinib Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Imatinib Drugs Sales by Region (2023-2028) & (K MT)
Table 9. Global Imatinib Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Imatinib Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Imatinib Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Imatinib Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Imatinib Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Imatinib Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Imatinib Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Imatinib Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Imatinib Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Imatinib Drugs Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Imatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Imatinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drugs as of 2021)
Table 21. Imatinib Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Imatinib Drugs Product Offered
Table 23. Date of Manufacturers Enter into Imatinib Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 26. Global Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 27. Global Imatinib Drugs Sales Share by Type (2017-2022)
Table 28. Global Imatinib Drugs Sales Share by Type (2023-2028)
Table 29. Global Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Imatinib Drugs Revenue Share by Type (2017-2022)
Table 32. Global Imatinib Drugs Revenue Share by Type (2023-2028)
Table 33. Imatinib Drugs Price by Type (2017-2022) & (USD/MT)
Table 34. Global Imatinib Drugs Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 36. Global Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 37. Global Imatinib Drugs Sales Share by Application (2017-2022)
Table 38. Global Imatinib Drugs Sales Share by Application (2023-2028)
Table 39. Global Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Imatinib Drugs Revenue Share by Application (2017-2022)
Table 42. Global Imatinib Drugs Revenue Share by Application (2023-2028)
Table 43. Imatinib Drugs Price by Application (2017-2022) & (USD/MT)
Table 44. Global Imatinib Drugs Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 46. North America Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 47. North America Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 50. North America Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 51. North America Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 54. North America Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 55. North America Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 58. Europe Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 59. Europe Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 62. Europe Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 63. Europe Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 66. Europe Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 67. Europe Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Imatinib Drugs Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Imatinib Drugs Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Imatinib Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Imatinib Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Imatinib Drugs Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Imatinib Drugs Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Imatinib Drugs Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Apotex Inc. Corporation Information
Table 106. Apotex Inc. Description and Major Businesses
Table 107. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Apotex Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Apotex Inc. Recent Developments
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Major Businesses
Table 112. Novartis Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Novartis Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novartis Recent Developments
Table 115. Sanofi S.A. Corporation Information
Table 116. Sanofi S.A. Description and Major Businesses
Table 117. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Sanofi S.A. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi S.A. Recent Developments
Table 120. Cipla Inc. Corporation Information
Table 121. Cipla Inc. Description and Major Businesses
Table 122. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Cipla Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Cipla Inc. Recent Developments
Table 125. Mylan Pharms Inc. Corporation Information
Table 126. Mylan Pharms Inc. Description and Major Businesses
Table 127. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Mylan Pharms Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Mylan Pharms Inc. Recent Developments
Table 130. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 131. Glenmark Pharmaceuticals Ltd. Description and Major Businesses
Table 132. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 135. Sun Pharmaceuticals Corporation Information
Table 136. Sun Pharmaceuticals Description and Major Businesses
Table 137. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Sun Pharmaceuticals Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Sun Pharmaceuticals Recent Developments
Table 140. Actavis Generics Corporation Information
Table 141. Actavis Generics Description and Major Businesses
Table 142. Actavis Generics Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Actavis Generics Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Actavis Generics Recent Developments
Table 145. Dr. Reddy's Laboratories Corporation Information
Table 146. Dr. Reddy's Laboratories Description and Major Businesses
Table 147. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Dr. Reddy's Laboratories Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Dr. Reddy's Laboratories Recent Developments
Table 150. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 151. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 152. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Imatinib Drugs Distributors List
Table 158. Imatinib Drugs Customers List
Table 159. Imatinib Drugs Market Trends
Table 160. Imatinib Drugs Market Drivers
Table 161. Imatinib Drugs Market Challenges
Table 162. Imatinib Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drugs Product Picture
Figure 3. Global Imatinib Drugs Market Share by Type in 2021 & 2028
Figure 3. Capsules Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Imatinib Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Drug Stores
Figure 8. Others
Figure 9. Imatinib Drugs Report Years Considered
Figure 10. Global Imatinib Drugs Sales 2017-2028 (K MT)
Figure 11. Global Imatinib Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Imatinib Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Imatinib Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Imatinib Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Imatinib Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Imatinib Drugs Sales YoY (2017-2028) & (K MT)
Figure 17. North America Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Imatinib Drugs Sales YoY (2017-2028) & (K MT)
Figure 19. Europe Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Imatinib Drugs Sales YoY (2017-2028) & (K MT)
Figure 21. Asia-Pacific Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Imatinib Drugs Sales YoY (2017-2028) & (K MT)
Figure 23. Latin America Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Imatinib Drugs Sales YoY (2017-2028) & (K MT)
Figure 25. Middle East & Africa Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Imatinib Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Imatinib Drugs in the World: Market Share by Imatinib Drugs Revenue in 2021
Figure 28. Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Imatinib Drugs Sales Share by Country (2017-2028)
Figure 38. North America Imatinib Drugs Revenue Share by Country (2017-2028)
Figure 39. U.S. Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 45. Europe Imatinib Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Imatinib Drugs Revenue Share by Country (2017-2028)
Figure 47. Germany Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. France Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Imatinib Drugs Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Imatinib Drugs Revenue Share by Region (2017-2028)
Figure 58. China Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. India Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 69. Latin America Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 71. Latin America Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Imatinib Drugs Sales Share by Country (2017-2028)
Figure 73. Latin America Imatinib Drugs Revenue Share by Country (2017-2028)
Figure 74. Mexico Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Imatinib Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Imatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Imatinib Drugs Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Imatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Imatinib Drugs Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Imatinib Drugs Revenue Share by Country (2017-2028)
Figure 83. Turkey Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Imatinib Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Imatinib Drugs Value Chain
Figure 87. Imatinib Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

DOWNLOAD SAMPLE